GlassScriptPhysician profile
Michelle Dowles Blanton
NPI 1841999364
$205.87
in general payments reported to CMS, 2019-2025
9 companies · $73.60 in 2025
The $73.60 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $116 · 2024: $16.06 · 2025: $73.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $39.97 | 2023 | Recarbrio, Dificid, Zerbaxa |
| Stryker Corporation | $29.57 | 2025 | Flowtriever |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.42 | 2025 | Jardiance |
| Argenx US, INC. | $22.60 | 2023 | Vyvgart |
| Seagen INC. | $19.92 | 2023 | Padcev |
| Amgen INC. | $18.76 | 2023 | Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.61 | 2025 | Xifaxan |
| Urgo Medical North America, LLC | $16.06 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Bioxcel Therapeutics, INC. | $14.96 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Blanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.